    <SEC-DOCUMENT>0001104659-25-072162-index.html : 20250730
    <SEC-HEADER>0001104659-25-072162.hdr.sgml : 20250730
    <ACCEPTANCE-DATETIME>20250730161225
    ACCESSION NUMBER:		0001104659-25-072162
    CONFORMED SUBMISSION TYPE:	PREM14A
    PUBLIC DOCUMENT COUNT:		12
    CONFORMED PERIOD OF REPORT:	20250910
    FILED AS OF DATE:		20250730
    DATE AS OF CHANGE:		20250730

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			ESSA Pharma Inc.
    		CENTRAL INDEX KEY:			0001633932
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				000000000
    		STATE OF INCORPORATION:			A1
    		FISCAL YEAR END:			0930

    	FILING VALUES:
    		FORM TYPE:		PREM14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-37410
    		FILM NUMBER:		251167171

    	BUSINESS ADDRESS:
    		STREET 1:		SUITE 720
    		STREET 2:		999 WEST BROADWAY
    		CITY:			VANCOUVER
    		STATE:			A1
    		ZIP:			V5Z 1K5
    		BUSINESS PHONE:		(778) 331-0962

    	MAIL ADDRESS:
    		STREET 1:		SUITE 720
    		STREET 2:		999 WEST BROADWAY
    		CITY:			VANCOUVER
    		STATE:			A1
    		ZIP:			V5Z 1K5
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>PREM14A
    <SEQUENCE>1
    <FILENAME>tm2520986-4_prem14a.htm
    <DESCRIPTION>PREM14A
    <TEXT>
    Document 1 - file: tm2520986-4_prem14a.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-FILING FEES
    <SEQUENCE>2
    <FILENAME>tm2520986d4_ex-filingfees.htm
    <DESCRIPTION>EX-FILING FEES
    <TEXT>
    Document 2 - file: tm2520986d4_ex-filingfees.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>ft_leerinkpartners-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: ft_leerinkpartners-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>lg_essa-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: lg_essa-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>5
    <FILENAME>lg_leerinkpartners-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 5 - file: lg_leerinkpartners-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>6
    <FILENAME>px_essapharmaproxy1pg01-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 6 - file: px_essapharmaproxy1pg01-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>7
    <FILENAME>px_essapharmaproxy1pg02-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 7 - file: px_essapharmaproxy1pg02-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>8
    <FILENAME>px_essapharmaproxy1pg03-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 8 - file: px_essapharmaproxy1pg03-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>9
    <FILENAME>px_essapharmaproxy1pg04-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 9 - file: px_essapharmaproxy1pg04-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>10
    <FILENAME>px_essapharmaproxy1pg05-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 10 - file: px_essapharmaproxy1pg05-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>11
    <FILENAME>px_essapharmaproxy1pg06-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 11 - file: px_essapharmaproxy1pg06-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>12
    <FILENAME>sg_leerinkpartnersllc-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 12 - file: sg_leerinkpartnersllc-bw.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>